Post-operative MRSA infections in head and neck surgery
Conclusions Patients who have a history of chemotherapy, immunosuppression, or recent hospital exposure prior to their surgery are at higher risk of developing MRSA-specific SSI and may benefit from prophylactic antibiotic therapy with appropriate coverage. Additionally, patients who develop MRSA SSIs are likely to have an extended postoperative inpatient stay.
Source: American Journal of Otolaryngology - Category: Endocrinology Source Type: research
More News: Antibiotic Therapy | Cancer | Cancer & Oncology | Chemotherapy | Endocrinology | Head and Neck Cancer | Infectious Diseases | MRSA | Staphylococcus Aureus | Statistics | Study | Superbugs